Vizora日本語

Kawaguchi Chemical IndustryKawaguchi Chemical Industry Co., Ltd4361東証スタンダード化学FY ending Nov 2025, consolidated, J-GAAP

Kawaguchi Chemical Industry FY ending Nov 2023 results

About 100% of Kawaguchi Chemical Industry's sales come from Pharmaceutical products, with Real estate leasing making up much of the rest.

Out of every ¥100 of sales, about ¥4 is left as operating profit.

Revenue changed +2.9% from the prior year, operating profit +20.4%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +2.9% · profit +20.4%, calculated from disclosed figures.

Operating leverage: 7.07× (profit growth ÷ revenue growth)

What changed from last year

FY ending Nov 2022 → FY ending Nov 2023

Revenue
+2.9%¥8.37B → ¥8.61B
Gross profit
+0.9%¥1.5B → ¥1.51B
Operating income
+20.4%¥293.9M → ¥353.9M
Net income attributable to owners
+16.8%¥218.9M → ¥255.5M
Operating cash flow
Back to profit-¥20.8M → ¥469.9M
Free cash flow
Back to profit-¥271.5M → ¥91.9M

Where the money goes

FY ending Nov 2022 → FY ending Nov 2023

Where ¥100 of sales goes

For every ¥100 Kawaguchi Chemical Industry sells, how much goes where, and how much is kept.

FY ending Nov 2023
Cost of sales
¥82
SG&A
¥14
Operating profit
¥4
Net profit kept
¥3

Annual margin trends

Gross margin17.6%
FY ending Nov 2019: 17.6%17.6%FY ending Nov 2020: 17.7%17.7%FY ending Nov 2021: 19.8%19.8%FY ending Nov 2022: 17.9%17.9%FY ending Nov 2023: 17.6%17.6%FY19FY20FY21FY22FY23
Operating margin4.1%
FY ending Nov 2019: 2.5%2.5%FY ending Nov 2020: 1.2%1.2%FY ending Nov 2021: 4.8%4.8%FY ending Nov 2022: 3.5%3.5%FY ending Nov 2023: 4.1%4.1%FY19FY20FY21FY22FY23
Net margin3.0%
FY ending Nov 2019: 2.0%2.0%FY ending Nov 2020: 0.9%0.9%FY ending Nov 2021: 3.5%3.5%FY ending Nov 2022: 2.6%2.6%FY ending Nov 2023: 3.0%3.0%FY19FY20FY21FY22FY23

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Nov 2023

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第124期(2024/12/01－2025/11/30)

    ID S100XLSD2026-02-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第123期(2023/12/01－2024/11/30)

    ID S100V9D52025-02-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第122期(2022/12/01－2023/11/30)

    ID S100SXGS2024-02-22Open

  • EDINET (FSA Japan)

    有価証券報告書－第121期(2021/12/01－2022/11/30)

    ID S100Q9LH2023-02-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第120期(令和2年12月1日－令和3年11月30日)

    ID S100NJFA2022-02-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第119期(令和1年12月1日－令和2年11月30日)

    ID S100KV872021-02-25Open

Extracted from XBRL: 47 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image